Cargando…

Cisplatin or carboplatin for advanced non-small cell lung cancer: does it really matter?

Detalles Bibliográficos
Autores principales:	Kesireddy, Meghana, Ganti, Apar Kishor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512469/ https://www.ncbi.nlm.nih.gov/pubmed/34733621 http://dx.doi.org/10.21037/tlcr-21-718

Ejemplares similares

Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)
por: Yellala, Amulya, et al.
Publicado: (2020)

Promising trends in lung cancer care, but are we overlooking the majority?
por: Sharma, Bhavina, et al.
Publicado: (2023)

EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
por: Reade, Chad A, et al.
Publicado: (2009)

Current concepts in the management of small cell lung cancer
por: Ganti, Apar Kishor, et al.
Publicado: (2013)

Impact of time-to-treatment on overall survival of non-small cell lung cancer patients—an analysis of the national cancer database
por: Anggondowati, Trisari, et al.
Publicado: (2020)

Does Specific Fungal Allergen Really Matter?
por: Yoo, Young
Publicado: (2016)

Does Particulate Matter Really Affect Sinusitis?
por: Lim, Suha, et al.
Publicado: (2021)

Real‐world outcomes of anti‐EGFR therapy in advanced non–small cell lung cancer EGFR mutated in Peru
por: Galvez‐Nino, Marco, et al.
Publicado: (2022)

Predicting liver and lung metastasis in esophageal cancer: does the site of primary tumor really matter?
por: Lam, Ka-On, et al.
Publicado: (2020)

Rapid sequence intubation: What does it mean? Does it really matter?
por: Tobias, Joseph D.
Publicado: (2014)

Pemetrexed plus cisplatin/carboplatin in previously treated locally advanced or metastatic non-small cell lung cancer patients
por: Zhang, Guan-Zhong, et al.
Publicado: (2010)

Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans
por: Azar, Ibrahim, et al.
Publicado: (2022)

Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non–small-cell lung cancer in the USA
por: Li, Yulin, et al.
Publicado: (2019)

Gradual sucrose gastric loading test: Does it really matter?
por: Amin, Pravin
Publicado: (2015)

Timing of frozen-thawed embryo transfers—does it really matter?
por: Klimczak, Amber, et al.
Publicado: (2020)

Correction: Real-world management of patients with epidermal growth factor receptor (EGFR) mutation-positive non-small-cell lung cancer in the USA
por: Li, Yulin, et al.
Publicado: (2019)

Course of acute myocarditis in athletes: Does the sport pattern really matter?
por: Brunetti, Giulia, et al.
Publicado: (2021)

Amrubicin: potential in combination with cisplatin or carboplatin to treat small-cell lung cancer
por: Ding, Qian, et al.
Publicado: (2013)

Cisplatin/carboplatin + etoposide + vinorelbine in advanced non-small-cell lung cancer: a multicentre randomised trial. Gruppo Oncologico Campano.
por: Comella, P., et al.
Publicado: (1996)

Characteristics of toxicity occurrence patterns in concurrent chemoradiotherapy after induction chemotherapy for patients with locally advanced non-small cell lung cancer: a pooled analysis based on individual patient data of CALGB/Alliance trials
por: Yang, Lexie Zidanyue, et al.
Publicado: (2022)

Systemic inflammation is associated with inferior disease control and survival in stage III non-small cell lung cancer
por: Keit, Emily, et al.
Publicado: (2021)

Does size really matter?
por: Heckel, David G
Publicado: (2020)

Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases
por: Li, Yue-Ya, et al.
Publicado: (2015)

Profile of vismodegib and its potential in the treatment of advanced basal cell carcinoma
por: Macha, Muzafar A, et al.
Publicado: (2013)

In time: how and when should we clamp the umbilical cord: does it really matter?
por: Vain, Nestor E.
Publicado: (2015)

Hypoxemia During One-Lung Ventilation: Does It Really Matter?
por: Durkin, Chris, et al.
Publicado: (2021)

Perihilar-cholangiocarcinoma: what really matters?
por: Di Benedetto, Fabrizio, et al.
Publicado: (2022)

Clinical Utility of Mobocertinib in the Treatment of NSCLC – Patient Selection and Reported Outcomes
por: Arnold, Abram, et al.
Publicado: (2023)

Does gene dosage really matter?
por: Graves, Jennifer A Marshall, et al.
Publicado: (2007)

Comparison of toxicity and outcomes of concurrent radiotherapy with carboplatin/paclitaxel or cisplatin/etoposide in stage III non–small cell lung cancer
por: Liew, Mun Sem, et al.
Publicado: (2013)

Comparing Docetaxel Plus Cisplatin with Paclitaxel Plus Carboplatin in Chemotherapy-Naïve Patients with Advanced Non-Small-Cell Lung Cancer: a Single Institute Study
por: Khodadad, Kian, et al.
Publicado: (2014)

Challenging “counterestablishment” archaeology: What really matters
por: Aldenderfer, Mark
Publicado: (2023)

Risk of thromboembolism in cisplatin versus carboplatin-treated patients with lung cancer
por: Kim, Eric S., et al.
Publicado: (2017)

Left Axis Deviation in Patients with Acute Heart Failure with Left Bundle Branch Block: Does It Really Matter?
por: Choi, Eue-Keun
Publicado: (2018)

Cisplatin/carboplatin cross-resistance in ovarian cancer.
por: Gore, M. E., et al.
Publicado: (1989)

Thyroid Prostate Axis. Does It Really Exist?
por: La Vignera, Sandro, et al.
Publicado: (2019)

HER-2/neu and CD117 (c-kit) overexpression in patients with pesticide exposure and extensive stage small cell lung carcinoma (ESSCLC)
por: Potti, Anil, et al.
Publicado: (2005)

Decannulation: in the ICU or in the ward? Does it really matter?
por: Milercy, O, et al.
Publicado: (2011)

Source of ICU admission: does it really matter?
por: Datta, A, et al.
Publicado: (2015)

Neurodegeneration in diabetic retinopathy: does it really matter?
por: Simó, Rafael, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g9a8q7c8ctgb32bjqt14j1vp6f